Global Interchangeable Biosimilar Humira Supply, Demand and Key Producers, 2023-2029
The global Interchangeable Biosimilar Humira market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Interchangeable Biosimilar Humira production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Interchangeable Biosimilar Humira, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Interchangeable Biosimilar Humira that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Interchangeable Biosimilar Humira total production and demand, 2018-2029, (K Units)
Global Interchangeable Biosimilar Humira total production value, 2018-2029, (USD Million)
Global Interchangeable Biosimilar Humira production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Interchangeable Biosimilar Humira consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Interchangeable Biosimilar Humira domestic production, consumption, key domestic manufacturers and share
Global Interchangeable Biosimilar Humira production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Interchangeable Biosimilar Humira production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Interchangeable Biosimilar Humira production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Interchangeable Biosimilar Humira market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Samsung Bioepis Co., Ltd., Sandoz International GmbH (Novartis AG), Mylan N.V., Boehringer Ingelheim International GmbH, Pfizer Inc., Fresenius Kabi AG, Coherus BioSciences, Inc., Biogen Inc. and AbbVie Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Interchangeable Biosimilar Humira market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Interchangeable Biosimilar Humira Market, By Region:
1. How big is the global Interchangeable Biosimilar Humira market?
2. What is the demand of the global Interchangeable Biosimilar Humira market?
3. What is the year over year growth of the global Interchangeable Biosimilar Humira market?
4. What is the production and production value of the global Interchangeable Biosimilar Humira market?
5. Who are the key producers in the global Interchangeable Biosimilar Humira market?
6. What are the growth factors driving the market demand?
This report studies the global Interchangeable Biosimilar Humira production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Interchangeable Biosimilar Humira, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Interchangeable Biosimilar Humira that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Interchangeable Biosimilar Humira total production and demand, 2018-2029, (K Units)
Global Interchangeable Biosimilar Humira total production value, 2018-2029, (USD Million)
Global Interchangeable Biosimilar Humira production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Interchangeable Biosimilar Humira consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Interchangeable Biosimilar Humira domestic production, consumption, key domestic manufacturers and share
Global Interchangeable Biosimilar Humira production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Interchangeable Biosimilar Humira production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Interchangeable Biosimilar Humira production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Interchangeable Biosimilar Humira market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Samsung Bioepis Co., Ltd., Sandoz International GmbH (Novartis AG), Mylan N.V., Boehringer Ingelheim International GmbH, Pfizer Inc., Fresenius Kabi AG, Coherus BioSciences, Inc., Biogen Inc. and AbbVie Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Interchangeable Biosimilar Humira market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Interchangeable Biosimilar Humira Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Subcutaneous (SC) Injection
- Intravenous (IV) Infusion
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Samsung Bioepis Co., Ltd.
- Sandoz International GmbH (Novartis AG)
- Mylan N.V.
- Boehringer Ingelheim International GmbH
- Pfizer Inc.
- Fresenius Kabi AG
- Coherus BioSciences, Inc.
- Biogen Inc.
- AbbVie Inc.
- Celltrion Inc.
- Amneal Pharmaceuticals, Inc.
- Lupin Pharmaceuticals, Inc.
- Merck & Co., Inc.
- Viatris Inc.imilar
- Amgen Inc.
1. How big is the global Interchangeable Biosimilar Humira market?
2. What is the demand of the global Interchangeable Biosimilar Humira market?
3. What is the year over year growth of the global Interchangeable Biosimilar Humira market?
4. What is the production and production value of the global Interchangeable Biosimilar Humira market?
5. Who are the key producers in the global Interchangeable Biosimilar Humira market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Interchangeable Biosimilar Humira Introduction
1.2 World Interchangeable Biosimilar Humira Supply & Forecast
1.2.1 World Interchangeable Biosimilar Humira Production Value (2018 & 2022 & 2029)
1.2.2 World Interchangeable Biosimilar Humira Production (2018-2029)
1.2.3 World Interchangeable Biosimilar Humira Pricing Trends (2018-2029)
1.3 World Interchangeable Biosimilar Humira Production by Region (Based on Production Site)
1.3.1 World Interchangeable Biosimilar Humira Production Value by Region (2018-2029)
1.3.2 World Interchangeable Biosimilar Humira Production by Region (2018-2029)
1.3.3 World Interchangeable Biosimilar Humira Average Price by Region (2018-2029)
1.3.4 North America Interchangeable Biosimilar Humira Production (2018-2029)
1.3.5 Europe Interchangeable Biosimilar Humira Production (2018-2029)
1.3.6 China Interchangeable Biosimilar Humira Production (2018-2029)
1.3.7 Japan Interchangeable Biosimilar Humira Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Interchangeable Biosimilar Humira Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Interchangeable Biosimilar Humira Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Interchangeable Biosimilar Humira Demand (2018-2029)
2.2 World Interchangeable Biosimilar Humira Consumption by Region
2.2.1 World Interchangeable Biosimilar Humira Consumption by Region (2018-2023)
2.2.2 World Interchangeable Biosimilar Humira Consumption Forecast by Region (2024-2029)
2.3 United States Interchangeable Biosimilar Humira Consumption (2018-2029)
2.4 China Interchangeable Biosimilar Humira Consumption (2018-2029)
2.5 Europe Interchangeable Biosimilar Humira Consumption (2018-2029)
2.6 Japan Interchangeable Biosimilar Humira Consumption (2018-2029)
2.7 South Korea Interchangeable Biosimilar Humira Consumption (2018-2029)
2.8 ASEAN Interchangeable Biosimilar Humira Consumption (2018-2029)
2.9 India Interchangeable Biosimilar Humira Consumption (2018-2029)
3 WORLD INTERCHANGEABLE BIOSIMILAR HUMIRA MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Interchangeable Biosimilar Humira Production Value by Manufacturer (2018-2023)
3.2 World Interchangeable Biosimilar Humira Production by Manufacturer (2018-2023)
3.3 World Interchangeable Biosimilar Humira Average Price by Manufacturer (2018-2023)
3.4 Interchangeable Biosimilar Humira Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Interchangeable Biosimilar Humira Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Interchangeable Biosimilar Humira in 2022
3.5.3 Global Concentration Ratios (CR8) for Interchangeable Biosimilar Humira in 2022
3.6 Interchangeable Biosimilar Humira Market: Overall Company Footprint Analysis
3.6.1 Interchangeable Biosimilar Humira Market: Region Footprint
3.6.2 Interchangeable Biosimilar Humira Market: Company Product Type Footprint
3.6.3 Interchangeable Biosimilar Humira Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Interchangeable Biosimilar Humira Production Value Comparison
4.1.1 United States VS China: Interchangeable Biosimilar Humira Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Interchangeable Biosimilar Humira Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Interchangeable Biosimilar Humira Production Comparison
4.2.1 United States VS China: Interchangeable Biosimilar Humira Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Interchangeable Biosimilar Humira Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Interchangeable Biosimilar Humira Consumption Comparison
4.3.1 United States VS China: Interchangeable Biosimilar Humira Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Interchangeable Biosimilar Humira Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Interchangeable Biosimilar Humira Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Interchangeable Biosimilar Humira Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Interchangeable Biosimilar Humira Production Value (2018-2023)
4.4.3 United States Based Manufacturers Interchangeable Biosimilar Humira Production (2018-2023)
4.5 China Based Interchangeable Biosimilar Humira Manufacturers and Market Share
4.5.1 China Based Interchangeable Biosimilar Humira Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Interchangeable Biosimilar Humira Production Value (2018-2023)
4.5.3 China Based Manufacturers Interchangeable Biosimilar Humira Production (2018-2023)
4.6 Rest of World Based Interchangeable Biosimilar Humira Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Interchangeable Biosimilar Humira Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Interchangeable Biosimilar Humira Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Interchangeable Biosimilar Humira Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Interchangeable Biosimilar Humira Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Subcutaneous (SC) Injection
5.2.2 Intravenous (IV) Infusion
5.3 Market Segment by Type
5.3.1 World Interchangeable Biosimilar Humira Production by Type (2018-2029)
5.3.2 World Interchangeable Biosimilar Humira Production Value by Type (2018-2029)
5.3.3 World Interchangeable Biosimilar Humira Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Interchangeable Biosimilar Humira Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Online Pharmacies
6.3 Market Segment by Application
6.3.1 World Interchangeable Biosimilar Humira Production by Application (2018-2029)
6.3.2 World Interchangeable Biosimilar Humira Production Value by Application (2018-2029)
6.3.3 World Interchangeable Biosimilar Humira Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Samsung Bioepis Co., Ltd.
7.1.1 Samsung Bioepis Co., Ltd. Details
7.1.2 Samsung Bioepis Co., Ltd. Major Business
7.1.3 Samsung Bioepis Co., Ltd. Interchangeable Biosimilar Humira Product and Services
7.1.4 Samsung Bioepis Co., Ltd. Interchangeable Biosimilar Humira Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Samsung Bioepis Co., Ltd. Recent Developments/Updates
7.1.6 Samsung Bioepis Co., Ltd. Competitive Strengths & Weaknesses
7.2 Sandoz International GmbH (Novartis AG)
7.2.1 Sandoz International GmbH (Novartis AG) Details
7.2.2 Sandoz International GmbH (Novartis AG) Major Business
7.2.3 Sandoz International GmbH (Novartis AG) Interchangeable Biosimilar Humira Product and Services
7.2.4 Sandoz International GmbH (Novartis AG) Interchangeable Biosimilar Humira Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Sandoz International GmbH (Novartis AG) Recent Developments/Updates
7.2.6 Sandoz International GmbH (Novartis AG) Competitive Strengths & Weaknesses
7.3 Mylan N.V.
7.3.1 Mylan N.V. Details
7.3.2 Mylan N.V. Major Business
7.3.3 Mylan N.V. Interchangeable Biosimilar Humira Product and Services
7.3.4 Mylan N.V. Interchangeable Biosimilar Humira Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Mylan N.V. Recent Developments/Updates
7.3.6 Mylan N.V. Competitive Strengths & Weaknesses
7.4 Boehringer Ingelheim International GmbH
7.4.1 Boehringer Ingelheim International GmbH Details
7.4.2 Boehringer Ingelheim International GmbH Major Business
7.4.3 Boehringer Ingelheim International GmbH Interchangeable Biosimilar Humira Product and Services
7.4.4 Boehringer Ingelheim International GmbH Interchangeable Biosimilar Humira Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Boehringer Ingelheim International GmbH Recent Developments/Updates
7.4.6 Boehringer Ingelheim International GmbH Competitive Strengths & Weaknesses
7.5 Pfizer Inc.
7.5.1 Pfizer Inc. Details
7.5.2 Pfizer Inc. Major Business
7.5.3 Pfizer Inc. Interchangeable Biosimilar Humira Product and Services
7.5.4 Pfizer Inc. Interchangeable Biosimilar Humira Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Pfizer Inc. Recent Developments/Updates
7.5.6 Pfizer Inc. Competitive Strengths & Weaknesses
7.6 Fresenius Kabi AG
7.6.1 Fresenius Kabi AG Details
7.6.2 Fresenius Kabi AG Major Business
7.6.3 Fresenius Kabi AG Interchangeable Biosimilar Humira Product and Services
7.6.4 Fresenius Kabi AG Interchangeable Biosimilar Humira Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Fresenius Kabi AG Recent Developments/Updates
7.6.6 Fresenius Kabi AG Competitive Strengths & Weaknesses
7.7 Coherus BioSciences, Inc.
7.7.1 Coherus BioSciences, Inc. Details
7.7.2 Coherus BioSciences, Inc. Major Business
7.7.3 Coherus BioSciences, Inc. Interchangeable Biosimilar Humira Product and Services
7.7.4 Coherus BioSciences, Inc. Interchangeable Biosimilar Humira Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Coherus BioSciences, Inc. Recent Developments/Updates
7.7.6 Coherus BioSciences, Inc. Competitive Strengths & Weaknesses
7.8 Biogen Inc.
7.8.1 Biogen Inc. Details
7.8.2 Biogen Inc. Major Business
7.8.3 Biogen Inc. Interchangeable Biosimilar Humira Product and Services
7.8.4 Biogen Inc. Interchangeable Biosimilar Humira Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Biogen Inc. Recent Developments/Updates
7.8.6 Biogen Inc. Competitive Strengths & Weaknesses
7.9 AbbVie Inc.
7.9.1 AbbVie Inc. Details
7.9.2 AbbVie Inc. Major Business
7.9.3 AbbVie Inc. Interchangeable Biosimilar Humira Product and Services
7.9.4 AbbVie Inc. Interchangeable Biosimilar Humira Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 AbbVie Inc. Recent Developments/Updates
7.9.6 AbbVie Inc. Competitive Strengths & Weaknesses
7.10 Celltrion Inc.
7.10.1 Celltrion Inc. Details
7.10.2 Celltrion Inc. Major Business
7.10.3 Celltrion Inc. Interchangeable Biosimilar Humira Product and Services
7.10.4 Celltrion Inc. Interchangeable Biosimilar Humira Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Celltrion Inc. Recent Developments/Updates
7.10.6 Celltrion Inc. Competitive Strengths & Weaknesses
7.11 Amneal Pharmaceuticals, Inc.
7.11.1 Amneal Pharmaceuticals, Inc. Details
7.11.2 Amneal Pharmaceuticals, Inc. Major Business
7.11.3 Amneal Pharmaceuticals, Inc. Interchangeable Biosimilar Humira Product and Services
7.11.4 Amneal Pharmaceuticals, Inc. Interchangeable Biosimilar Humira Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Amneal Pharmaceuticals, Inc. Recent Developments/Updates
7.11.6 Amneal Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
7.12 Lupin Pharmaceuticals, Inc.
7.12.1 Lupin Pharmaceuticals, Inc. Details
7.12.2 Lupin Pharmaceuticals, Inc. Major Business
7.12.3 Lupin Pharmaceuticals, Inc. Interchangeable Biosimilar Humira Product and Services
7.12.4 Lupin Pharmaceuticals, Inc. Interchangeable Biosimilar Humira Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Lupin Pharmaceuticals, Inc. Recent Developments/Updates
7.12.6 Lupin Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
7.13 Merck & Co., Inc.
7.13.1 Merck & Co., Inc. Details
7.13.2 Merck & Co., Inc. Major Business
7.13.3 Merck & Co., Inc. Interchangeable Biosimilar Humira Product and Services
7.13.4 Merck & Co., Inc. Interchangeable Biosimilar Humira Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Merck & Co., Inc. Recent Developments/Updates
7.13.6 Merck & Co., Inc. Competitive Strengths & Weaknesses
7.14 Viatris Inc.imilar
7.14.1 Viatris Inc.imilar Details
7.14.2 Viatris Inc.imilar Major Business
7.14.3 Viatris Inc.imilar Interchangeable Biosimilar Humira Product and Services
7.14.4 Viatris Inc.imilar Interchangeable Biosimilar Humira Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Viatris Inc.imilar Recent Developments/Updates
7.14.6 Viatris Inc.imilar Competitive Strengths & Weaknesses
7.15 Amgen Inc.
7.15.1 Amgen Inc. Details
7.15.2 Amgen Inc. Major Business
7.15.3 Amgen Inc. Interchangeable Biosimilar Humira Product and Services
7.15.4 Amgen Inc. Interchangeable Biosimilar Humira Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Amgen Inc. Recent Developments/Updates
7.15.6 Amgen Inc. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Interchangeable Biosimilar Humira Industry Chain
8.2 Interchangeable Biosimilar Humira Upstream Analysis
8.2.1 Interchangeable Biosimilar Humira Core Raw Materials
8.2.2 Main Manufacturers of Interchangeable Biosimilar Humira Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Interchangeable Biosimilar Humira Production Mode
8.6 Interchangeable Biosimilar Humira Procurement Model
8.7 Interchangeable Biosimilar Humira Industry Sales Model and Sales Channels
8.7.1 Interchangeable Biosimilar Humira Sales Model
8.7.2 Interchangeable Biosimilar Humira Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Interchangeable Biosimilar Humira Introduction
1.2 World Interchangeable Biosimilar Humira Supply & Forecast
1.2.1 World Interchangeable Biosimilar Humira Production Value (2018 & 2022 & 2029)
1.2.2 World Interchangeable Biosimilar Humira Production (2018-2029)
1.2.3 World Interchangeable Biosimilar Humira Pricing Trends (2018-2029)
1.3 World Interchangeable Biosimilar Humira Production by Region (Based on Production Site)
1.3.1 World Interchangeable Biosimilar Humira Production Value by Region (2018-2029)
1.3.2 World Interchangeable Biosimilar Humira Production by Region (2018-2029)
1.3.3 World Interchangeable Biosimilar Humira Average Price by Region (2018-2029)
1.3.4 North America Interchangeable Biosimilar Humira Production (2018-2029)
1.3.5 Europe Interchangeable Biosimilar Humira Production (2018-2029)
1.3.6 China Interchangeable Biosimilar Humira Production (2018-2029)
1.3.7 Japan Interchangeable Biosimilar Humira Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Interchangeable Biosimilar Humira Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Interchangeable Biosimilar Humira Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Interchangeable Biosimilar Humira Demand (2018-2029)
2.2 World Interchangeable Biosimilar Humira Consumption by Region
2.2.1 World Interchangeable Biosimilar Humira Consumption by Region (2018-2023)
2.2.2 World Interchangeable Biosimilar Humira Consumption Forecast by Region (2024-2029)
2.3 United States Interchangeable Biosimilar Humira Consumption (2018-2029)
2.4 China Interchangeable Biosimilar Humira Consumption (2018-2029)
2.5 Europe Interchangeable Biosimilar Humira Consumption (2018-2029)
2.6 Japan Interchangeable Biosimilar Humira Consumption (2018-2029)
2.7 South Korea Interchangeable Biosimilar Humira Consumption (2018-2029)
2.8 ASEAN Interchangeable Biosimilar Humira Consumption (2018-2029)
2.9 India Interchangeable Biosimilar Humira Consumption (2018-2029)
3 WORLD INTERCHANGEABLE BIOSIMILAR HUMIRA MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Interchangeable Biosimilar Humira Production Value by Manufacturer (2018-2023)
3.2 World Interchangeable Biosimilar Humira Production by Manufacturer (2018-2023)
3.3 World Interchangeable Biosimilar Humira Average Price by Manufacturer (2018-2023)
3.4 Interchangeable Biosimilar Humira Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Interchangeable Biosimilar Humira Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Interchangeable Biosimilar Humira in 2022
3.5.3 Global Concentration Ratios (CR8) for Interchangeable Biosimilar Humira in 2022
3.6 Interchangeable Biosimilar Humira Market: Overall Company Footprint Analysis
3.6.1 Interchangeable Biosimilar Humira Market: Region Footprint
3.6.2 Interchangeable Biosimilar Humira Market: Company Product Type Footprint
3.6.3 Interchangeable Biosimilar Humira Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Interchangeable Biosimilar Humira Production Value Comparison
4.1.1 United States VS China: Interchangeable Biosimilar Humira Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Interchangeable Biosimilar Humira Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Interchangeable Biosimilar Humira Production Comparison
4.2.1 United States VS China: Interchangeable Biosimilar Humira Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Interchangeable Biosimilar Humira Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Interchangeable Biosimilar Humira Consumption Comparison
4.3.1 United States VS China: Interchangeable Biosimilar Humira Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Interchangeable Biosimilar Humira Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Interchangeable Biosimilar Humira Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Interchangeable Biosimilar Humira Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Interchangeable Biosimilar Humira Production Value (2018-2023)
4.4.3 United States Based Manufacturers Interchangeable Biosimilar Humira Production (2018-2023)
4.5 China Based Interchangeable Biosimilar Humira Manufacturers and Market Share
4.5.1 China Based Interchangeable Biosimilar Humira Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Interchangeable Biosimilar Humira Production Value (2018-2023)
4.5.3 China Based Manufacturers Interchangeable Biosimilar Humira Production (2018-2023)
4.6 Rest of World Based Interchangeable Biosimilar Humira Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Interchangeable Biosimilar Humira Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Interchangeable Biosimilar Humira Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Interchangeable Biosimilar Humira Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Interchangeable Biosimilar Humira Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Subcutaneous (SC) Injection
5.2.2 Intravenous (IV) Infusion
5.3 Market Segment by Type
5.3.1 World Interchangeable Biosimilar Humira Production by Type (2018-2029)
5.3.2 World Interchangeable Biosimilar Humira Production Value by Type (2018-2029)
5.3.3 World Interchangeable Biosimilar Humira Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Interchangeable Biosimilar Humira Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Online Pharmacies
6.3 Market Segment by Application
6.3.1 World Interchangeable Biosimilar Humira Production by Application (2018-2029)
6.3.2 World Interchangeable Biosimilar Humira Production Value by Application (2018-2029)
6.3.3 World Interchangeable Biosimilar Humira Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Samsung Bioepis Co., Ltd.
7.1.1 Samsung Bioepis Co., Ltd. Details
7.1.2 Samsung Bioepis Co., Ltd. Major Business
7.1.3 Samsung Bioepis Co., Ltd. Interchangeable Biosimilar Humira Product and Services
7.1.4 Samsung Bioepis Co., Ltd. Interchangeable Biosimilar Humira Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Samsung Bioepis Co., Ltd. Recent Developments/Updates
7.1.6 Samsung Bioepis Co., Ltd. Competitive Strengths & Weaknesses
7.2 Sandoz International GmbH (Novartis AG)
7.2.1 Sandoz International GmbH (Novartis AG) Details
7.2.2 Sandoz International GmbH (Novartis AG) Major Business
7.2.3 Sandoz International GmbH (Novartis AG) Interchangeable Biosimilar Humira Product and Services
7.2.4 Sandoz International GmbH (Novartis AG) Interchangeable Biosimilar Humira Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Sandoz International GmbH (Novartis AG) Recent Developments/Updates
7.2.6 Sandoz International GmbH (Novartis AG) Competitive Strengths & Weaknesses
7.3 Mylan N.V.
7.3.1 Mylan N.V. Details
7.3.2 Mylan N.V. Major Business
7.3.3 Mylan N.V. Interchangeable Biosimilar Humira Product and Services
7.3.4 Mylan N.V. Interchangeable Biosimilar Humira Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Mylan N.V. Recent Developments/Updates
7.3.6 Mylan N.V. Competitive Strengths & Weaknesses
7.4 Boehringer Ingelheim International GmbH
7.4.1 Boehringer Ingelheim International GmbH Details
7.4.2 Boehringer Ingelheim International GmbH Major Business
7.4.3 Boehringer Ingelheim International GmbH Interchangeable Biosimilar Humira Product and Services
7.4.4 Boehringer Ingelheim International GmbH Interchangeable Biosimilar Humira Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Boehringer Ingelheim International GmbH Recent Developments/Updates
7.4.6 Boehringer Ingelheim International GmbH Competitive Strengths & Weaknesses
7.5 Pfizer Inc.
7.5.1 Pfizer Inc. Details
7.5.2 Pfizer Inc. Major Business
7.5.3 Pfizer Inc. Interchangeable Biosimilar Humira Product and Services
7.5.4 Pfizer Inc. Interchangeable Biosimilar Humira Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Pfizer Inc. Recent Developments/Updates
7.5.6 Pfizer Inc. Competitive Strengths & Weaknesses
7.6 Fresenius Kabi AG
7.6.1 Fresenius Kabi AG Details
7.6.2 Fresenius Kabi AG Major Business
7.6.3 Fresenius Kabi AG Interchangeable Biosimilar Humira Product and Services
7.6.4 Fresenius Kabi AG Interchangeable Biosimilar Humira Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Fresenius Kabi AG Recent Developments/Updates
7.6.6 Fresenius Kabi AG Competitive Strengths & Weaknesses
7.7 Coherus BioSciences, Inc.
7.7.1 Coherus BioSciences, Inc. Details
7.7.2 Coherus BioSciences, Inc. Major Business
7.7.3 Coherus BioSciences, Inc. Interchangeable Biosimilar Humira Product and Services
7.7.4 Coherus BioSciences, Inc. Interchangeable Biosimilar Humira Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Coherus BioSciences, Inc. Recent Developments/Updates
7.7.6 Coherus BioSciences, Inc. Competitive Strengths & Weaknesses
7.8 Biogen Inc.
7.8.1 Biogen Inc. Details
7.8.2 Biogen Inc. Major Business
7.8.3 Biogen Inc. Interchangeable Biosimilar Humira Product and Services
7.8.4 Biogen Inc. Interchangeable Biosimilar Humira Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Biogen Inc. Recent Developments/Updates
7.8.6 Biogen Inc. Competitive Strengths & Weaknesses
7.9 AbbVie Inc.
7.9.1 AbbVie Inc. Details
7.9.2 AbbVie Inc. Major Business
7.9.3 AbbVie Inc. Interchangeable Biosimilar Humira Product and Services
7.9.4 AbbVie Inc. Interchangeable Biosimilar Humira Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 AbbVie Inc. Recent Developments/Updates
7.9.6 AbbVie Inc. Competitive Strengths & Weaknesses
7.10 Celltrion Inc.
7.10.1 Celltrion Inc. Details
7.10.2 Celltrion Inc. Major Business
7.10.3 Celltrion Inc. Interchangeable Biosimilar Humira Product and Services
7.10.4 Celltrion Inc. Interchangeable Biosimilar Humira Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Celltrion Inc. Recent Developments/Updates
7.10.6 Celltrion Inc. Competitive Strengths & Weaknesses
7.11 Amneal Pharmaceuticals, Inc.
7.11.1 Amneal Pharmaceuticals, Inc. Details
7.11.2 Amneal Pharmaceuticals, Inc. Major Business
7.11.3 Amneal Pharmaceuticals, Inc. Interchangeable Biosimilar Humira Product and Services
7.11.4 Amneal Pharmaceuticals, Inc. Interchangeable Biosimilar Humira Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Amneal Pharmaceuticals, Inc. Recent Developments/Updates
7.11.6 Amneal Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
7.12 Lupin Pharmaceuticals, Inc.
7.12.1 Lupin Pharmaceuticals, Inc. Details
7.12.2 Lupin Pharmaceuticals, Inc. Major Business
7.12.3 Lupin Pharmaceuticals, Inc. Interchangeable Biosimilar Humira Product and Services
7.12.4 Lupin Pharmaceuticals, Inc. Interchangeable Biosimilar Humira Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Lupin Pharmaceuticals, Inc. Recent Developments/Updates
7.12.6 Lupin Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
7.13 Merck & Co., Inc.
7.13.1 Merck & Co., Inc. Details
7.13.2 Merck & Co., Inc. Major Business
7.13.3 Merck & Co., Inc. Interchangeable Biosimilar Humira Product and Services
7.13.4 Merck & Co., Inc. Interchangeable Biosimilar Humira Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Merck & Co., Inc. Recent Developments/Updates
7.13.6 Merck & Co., Inc. Competitive Strengths & Weaknesses
7.14 Viatris Inc.imilar
7.14.1 Viatris Inc.imilar Details
7.14.2 Viatris Inc.imilar Major Business
7.14.3 Viatris Inc.imilar Interchangeable Biosimilar Humira Product and Services
7.14.4 Viatris Inc.imilar Interchangeable Biosimilar Humira Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Viatris Inc.imilar Recent Developments/Updates
7.14.6 Viatris Inc.imilar Competitive Strengths & Weaknesses
7.15 Amgen Inc.
7.15.1 Amgen Inc. Details
7.15.2 Amgen Inc. Major Business
7.15.3 Amgen Inc. Interchangeable Biosimilar Humira Product and Services
7.15.4 Amgen Inc. Interchangeable Biosimilar Humira Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Amgen Inc. Recent Developments/Updates
7.15.6 Amgen Inc. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Interchangeable Biosimilar Humira Industry Chain
8.2 Interchangeable Biosimilar Humira Upstream Analysis
8.2.1 Interchangeable Biosimilar Humira Core Raw Materials
8.2.2 Main Manufacturers of Interchangeable Biosimilar Humira Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Interchangeable Biosimilar Humira Production Mode
8.6 Interchangeable Biosimilar Humira Procurement Model
8.7 Interchangeable Biosimilar Humira Industry Sales Model and Sales Channels
8.7.1 Interchangeable Biosimilar Humira Sales Model
8.7.2 Interchangeable Biosimilar Humira Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Interchangeable Biosimilar Humira Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Interchangeable Biosimilar Humira Production Value by Region (2018-2023) & (USD Million)
Table 3. World Interchangeable Biosimilar Humira Production Value by Region (2024-2029) & (USD Million)
Table 4. World Interchangeable Biosimilar Humira Production Value Market Share by Region (2018-2023)
Table 5. World Interchangeable Biosimilar Humira Production Value Market Share by Region (2024-2029)
Table 6. World Interchangeable Biosimilar Humira Production by Region (2018-2023) & (K Units)
Table 7. World Interchangeable Biosimilar Humira Production by Region (2024-2029) & (K Units)
Table 8. World Interchangeable Biosimilar Humira Production Market Share by Region (2018-2023)
Table 9. World Interchangeable Biosimilar Humira Production Market Share by Region (2024-2029)
Table 10. World Interchangeable Biosimilar Humira Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Interchangeable Biosimilar Humira Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Interchangeable Biosimilar Humira Major Market Trends
Table 13. World Interchangeable Biosimilar Humira Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Interchangeable Biosimilar Humira Consumption by Region (2018-2023) & (K Units)
Table 15. World Interchangeable Biosimilar Humira Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Interchangeable Biosimilar Humira Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Interchangeable Biosimilar Humira Producers in 2022
Table 18. World Interchangeable Biosimilar Humira Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Interchangeable Biosimilar Humira Producers in 2022
Table 20. World Interchangeable Biosimilar Humira Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Interchangeable Biosimilar Humira Company Evaluation Quadrant
Table 22. World Interchangeable Biosimilar Humira Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Interchangeable Biosimilar Humira Production Site of Key Manufacturer
Table 24. Interchangeable Biosimilar Humira Market: Company Product Type Footprint
Table 25. Interchangeable Biosimilar Humira Market: Company Product Application Footprint
Table 26. Interchangeable Biosimilar Humira Competitive Factors
Table 27. Interchangeable Biosimilar Humira New Entrant and Capacity Expansion Plans
Table 28. Interchangeable Biosimilar Humira Mergers & Acquisitions Activity
Table 29. United States VS China Interchangeable Biosimilar Humira Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Interchangeable Biosimilar Humira Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Interchangeable Biosimilar Humira Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Interchangeable Biosimilar Humira Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Interchangeable Biosimilar Humira Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Interchangeable Biosimilar Humira Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Interchangeable Biosimilar Humira Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Interchangeable Biosimilar Humira Production Market Share (2018-2023)
Table 37. China Based Interchangeable Biosimilar Humira Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Interchangeable Biosimilar Humira Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Interchangeable Biosimilar Humira Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Interchangeable Biosimilar Humira Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Interchangeable Biosimilar Humira Production Market Share (2018-2023)
Table 42. Rest of World Based Interchangeable Biosimilar Humira Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Interchangeable Biosimilar Humira Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Interchangeable Biosimilar Humira Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Interchangeable Biosimilar Humira Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Interchangeable Biosimilar Humira Production Market Share (2018-2023)
Table 47. World Interchangeable Biosimilar Humira Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Interchangeable Biosimilar Humira Production by Type (2018-2023) & (K Units)
Table 49. World Interchangeable Biosimilar Humira Production by Type (2024-2029) & (K Units)
Table 50. World Interchangeable Biosimilar Humira Production Value by Type (2018-2023) & (USD Million)
Table 51. World Interchangeable Biosimilar Humira Production Value by Type (2024-2029) & (USD Million)
Table 52. World Interchangeable Biosimilar Humira Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Interchangeable Biosimilar Humira Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Interchangeable Biosimilar Humira Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Interchangeable Biosimilar Humira Production by Application (2018-2023) & (K Units)
Table 56. World Interchangeable Biosimilar Humira Production by Application (2024-2029) & (K Units)
Table 57. World Interchangeable Biosimilar Humira Production Value by Application (2018-2023) & (USD Million)
Table 58. World Interchangeable Biosimilar Humira Production Value by Application (2024-2029) & (USD Million)
Table 59. World Interchangeable Biosimilar Humira Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Interchangeable Biosimilar Humira Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Samsung Bioepis Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 62. Samsung Bioepis Co., Ltd. Major Business
Table 63. Samsung Bioepis Co., Ltd. Interchangeable Biosimilar Humira Product and Services
Table 64. Samsung Bioepis Co., Ltd. Interchangeable Biosimilar Humira Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Samsung Bioepis Co., Ltd. Recent Developments/Updates
Table 66. Samsung Bioepis Co., Ltd. Competitive Strengths & Weaknesses
Table 67. Sandoz International GmbH (Novartis AG) Basic Information, Manufacturing Base and Competitors
Table 68. Sandoz International GmbH (Novartis AG) Major Business
Table 69. Sandoz International GmbH (Novartis AG) Interchangeable Biosimilar Humira Product and Services
Table 70. Sandoz International GmbH (Novartis AG) Interchangeable Biosimilar Humira Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Sandoz International GmbH (Novartis AG) Recent Developments/Updates
Table 72. Sandoz International GmbH (Novartis AG) Competitive Strengths & Weaknesses
Table 73. Mylan N.V. Basic Information, Manufacturing Base and Competitors
Table 74. Mylan N.V. Major Business
Table 75. Mylan N.V. Interchangeable Biosimilar Humira Product and Services
Table 76. Mylan N.V. Interchangeable Biosimilar Humira Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Mylan N.V. Recent Developments/Updates
Table 78. Mylan N.V. Competitive Strengths & Weaknesses
Table 79. Boehringer Ingelheim International GmbH Basic Information, Manufacturing Base and Competitors
Table 80. Boehringer Ingelheim International GmbH Major Business
Table 81. Boehringer Ingelheim International GmbH Interchangeable Biosimilar Humira Product and Services
Table 82. Boehringer Ingelheim International GmbH Interchangeable Biosimilar Humira Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Boehringer Ingelheim International GmbH Recent Developments/Updates
Table 84. Boehringer Ingelheim International GmbH Competitive Strengths & Weaknesses
Table 85. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 86. Pfizer Inc. Major Business
Table 87. Pfizer Inc. Interchangeable Biosimilar Humira Product and Services
Table 88. Pfizer Inc. Interchangeable Biosimilar Humira Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Pfizer Inc. Recent Developments/Updates
Table 90. Pfizer Inc. Competitive Strengths & Weaknesses
Table 91. Fresenius Kabi AG Basic Information, Manufacturing Base and Competitors
Table 92. Fresenius Kabi AG Major Business
Table 93. Fresenius Kabi AG Interchangeable Biosimilar Humira Product and Services
Table 94. Fresenius Kabi AG Interchangeable Biosimilar Humira Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Fresenius Kabi AG Recent Developments/Updates
Table 96. Fresenius Kabi AG Competitive Strengths & Weaknesses
Table 97. Coherus BioSciences, Inc. Basic Information, Manufacturing Base and Competitors
Table 98. Coherus BioSciences, Inc. Major Business
Table 99. Coherus BioSciences, Inc. Interchangeable Biosimilar Humira Product and Services
Table 100. Coherus BioSciences, Inc. Interchangeable Biosimilar Humira Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Coherus BioSciences, Inc. Recent Developments/Updates
Table 102. Coherus BioSciences, Inc. Competitive Strengths & Weaknesses
Table 103. Biogen Inc. Basic Information, Manufacturing Base and Competitors
Table 104. Biogen Inc. Major Business
Table 105. Biogen Inc. Interchangeable Biosimilar Humira Product and Services
Table 106. Biogen Inc. Interchangeable Biosimilar Humira Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Biogen Inc. Recent Developments/Updates
Table 108. Biogen Inc. Competitive Strengths & Weaknesses
Table 109. AbbVie Inc. Basic Information, Manufacturing Base and Competitors
Table 110. AbbVie Inc. Major Business
Table 111. AbbVie Inc. Interchangeable Biosimilar Humira Product and Services
Table 112. AbbVie Inc. Interchangeable Biosimilar Humira Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. AbbVie Inc. Recent Developments/Updates
Table 114. AbbVie Inc. Competitive Strengths & Weaknesses
Table 115. Celltrion Inc. Basic Information, Manufacturing Base and Competitors
Table 116. Celltrion Inc. Major Business
Table 117. Celltrion Inc. Interchangeable Biosimilar Humira Product and Services
Table 118. Celltrion Inc. Interchangeable Biosimilar Humira Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Celltrion Inc. Recent Developments/Updates
Table 120. Celltrion Inc. Competitive Strengths & Weaknesses
Table 121. Amneal Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 122. Amneal Pharmaceuticals, Inc. Major Business
Table 123. Amneal Pharmaceuticals, Inc. Interchangeable Biosimilar Humira Product and Services
Table 124. Amneal Pharmaceuticals, Inc. Interchangeable Biosimilar Humira Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Amneal Pharmaceuticals, Inc. Recent Developments/Updates
Table 126. Amneal Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
Table 127. Lupin Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 128. Lupin Pharmaceuticals, Inc. Major Business
Table 129. Lupin Pharmaceuticals, Inc. Interchangeable Biosimilar Humira Product and Services
Table 130. Lupin Pharmaceuticals, Inc. Interchangeable Biosimilar Humira Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Lupin Pharmaceuticals, Inc. Recent Developments/Updates
Table 132. Lupin Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
Table 133. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 134. Merck & Co., Inc. Major Business
Table 135. Merck & Co., Inc. Interchangeable Biosimilar Humira Product and Services
Table 136. Merck & Co., Inc. Interchangeable Biosimilar Humira Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Merck & Co., Inc. Recent Developments/Updates
Table 138. Merck & Co., Inc. Competitive Strengths & Weaknesses
Table 139. Viatris Inc.imilar Basic Information, Manufacturing Base and Competitors
Table 140. Viatris Inc.imilar Major Business
Table 141. Viatris Inc.imilar Interchangeable Biosimilar Humira Product and Services
Table 142. Viatris Inc.imilar Interchangeable Biosimilar Humira Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Viatris Inc.imilar Recent Developments/Updates
Table 144. Amgen Inc. Basic Information, Manufacturing Base and Competitors
Table 145. Amgen Inc. Major Business
Table 146. Amgen Inc. Interchangeable Biosimilar Humira Product and Services
Table 147. Amgen Inc. Interchangeable Biosimilar Humira Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 148. Global Key Players of Interchangeable Biosimilar Humira Upstream (Raw Materials)
Table 149. Interchangeable Biosimilar Humira Typical Customers
Table 150. Interchangeable Biosimilar Humira Typical Distributors
Table 1. World Interchangeable Biosimilar Humira Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Interchangeable Biosimilar Humira Production Value by Region (2018-2023) & (USD Million)
Table 3. World Interchangeable Biosimilar Humira Production Value by Region (2024-2029) & (USD Million)
Table 4. World Interchangeable Biosimilar Humira Production Value Market Share by Region (2018-2023)
Table 5. World Interchangeable Biosimilar Humira Production Value Market Share by Region (2024-2029)
Table 6. World Interchangeable Biosimilar Humira Production by Region (2018-2023) & (K Units)
Table 7. World Interchangeable Biosimilar Humira Production by Region (2024-2029) & (K Units)
Table 8. World Interchangeable Biosimilar Humira Production Market Share by Region (2018-2023)
Table 9. World Interchangeable Biosimilar Humira Production Market Share by Region (2024-2029)
Table 10. World Interchangeable Biosimilar Humira Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Interchangeable Biosimilar Humira Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Interchangeable Biosimilar Humira Major Market Trends
Table 13. World Interchangeable Biosimilar Humira Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Interchangeable Biosimilar Humira Consumption by Region (2018-2023) & (K Units)
Table 15. World Interchangeable Biosimilar Humira Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Interchangeable Biosimilar Humira Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Interchangeable Biosimilar Humira Producers in 2022
Table 18. World Interchangeable Biosimilar Humira Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Interchangeable Biosimilar Humira Producers in 2022
Table 20. World Interchangeable Biosimilar Humira Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Interchangeable Biosimilar Humira Company Evaluation Quadrant
Table 22. World Interchangeable Biosimilar Humira Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Interchangeable Biosimilar Humira Production Site of Key Manufacturer
Table 24. Interchangeable Biosimilar Humira Market: Company Product Type Footprint
Table 25. Interchangeable Biosimilar Humira Market: Company Product Application Footprint
Table 26. Interchangeable Biosimilar Humira Competitive Factors
Table 27. Interchangeable Biosimilar Humira New Entrant and Capacity Expansion Plans
Table 28. Interchangeable Biosimilar Humira Mergers & Acquisitions Activity
Table 29. United States VS China Interchangeable Biosimilar Humira Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Interchangeable Biosimilar Humira Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Interchangeable Biosimilar Humira Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Interchangeable Biosimilar Humira Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Interchangeable Biosimilar Humira Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Interchangeable Biosimilar Humira Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Interchangeable Biosimilar Humira Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Interchangeable Biosimilar Humira Production Market Share (2018-2023)
Table 37. China Based Interchangeable Biosimilar Humira Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Interchangeable Biosimilar Humira Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Interchangeable Biosimilar Humira Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Interchangeable Biosimilar Humira Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Interchangeable Biosimilar Humira Production Market Share (2018-2023)
Table 42. Rest of World Based Interchangeable Biosimilar Humira Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Interchangeable Biosimilar Humira Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Interchangeable Biosimilar Humira Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Interchangeable Biosimilar Humira Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Interchangeable Biosimilar Humira Production Market Share (2018-2023)
Table 47. World Interchangeable Biosimilar Humira Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Interchangeable Biosimilar Humira Production by Type (2018-2023) & (K Units)
Table 49. World Interchangeable Biosimilar Humira Production by Type (2024-2029) & (K Units)
Table 50. World Interchangeable Biosimilar Humira Production Value by Type (2018-2023) & (USD Million)
Table 51. World Interchangeable Biosimilar Humira Production Value by Type (2024-2029) & (USD Million)
Table 52. World Interchangeable Biosimilar Humira Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Interchangeable Biosimilar Humira Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Interchangeable Biosimilar Humira Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Interchangeable Biosimilar Humira Production by Application (2018-2023) & (K Units)
Table 56. World Interchangeable Biosimilar Humira Production by Application (2024-2029) & (K Units)
Table 57. World Interchangeable Biosimilar Humira Production Value by Application (2018-2023) & (USD Million)
Table 58. World Interchangeable Biosimilar Humira Production Value by Application (2024-2029) & (USD Million)
Table 59. World Interchangeable Biosimilar Humira Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Interchangeable Biosimilar Humira Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Samsung Bioepis Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 62. Samsung Bioepis Co., Ltd. Major Business
Table 63. Samsung Bioepis Co., Ltd. Interchangeable Biosimilar Humira Product and Services
Table 64. Samsung Bioepis Co., Ltd. Interchangeable Biosimilar Humira Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Samsung Bioepis Co., Ltd. Recent Developments/Updates
Table 66. Samsung Bioepis Co., Ltd. Competitive Strengths & Weaknesses
Table 67. Sandoz International GmbH (Novartis AG) Basic Information, Manufacturing Base and Competitors
Table 68. Sandoz International GmbH (Novartis AG) Major Business
Table 69. Sandoz International GmbH (Novartis AG) Interchangeable Biosimilar Humira Product and Services
Table 70. Sandoz International GmbH (Novartis AG) Interchangeable Biosimilar Humira Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Sandoz International GmbH (Novartis AG) Recent Developments/Updates
Table 72. Sandoz International GmbH (Novartis AG) Competitive Strengths & Weaknesses
Table 73. Mylan N.V. Basic Information, Manufacturing Base and Competitors
Table 74. Mylan N.V. Major Business
Table 75. Mylan N.V. Interchangeable Biosimilar Humira Product and Services
Table 76. Mylan N.V. Interchangeable Biosimilar Humira Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Mylan N.V. Recent Developments/Updates
Table 78. Mylan N.V. Competitive Strengths & Weaknesses
Table 79. Boehringer Ingelheim International GmbH Basic Information, Manufacturing Base and Competitors
Table 80. Boehringer Ingelheim International GmbH Major Business
Table 81. Boehringer Ingelheim International GmbH Interchangeable Biosimilar Humira Product and Services
Table 82. Boehringer Ingelheim International GmbH Interchangeable Biosimilar Humira Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Boehringer Ingelheim International GmbH Recent Developments/Updates
Table 84. Boehringer Ingelheim International GmbH Competitive Strengths & Weaknesses
Table 85. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 86. Pfizer Inc. Major Business
Table 87. Pfizer Inc. Interchangeable Biosimilar Humira Product and Services
Table 88. Pfizer Inc. Interchangeable Biosimilar Humira Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Pfizer Inc. Recent Developments/Updates
Table 90. Pfizer Inc. Competitive Strengths & Weaknesses
Table 91. Fresenius Kabi AG Basic Information, Manufacturing Base and Competitors
Table 92. Fresenius Kabi AG Major Business
Table 93. Fresenius Kabi AG Interchangeable Biosimilar Humira Product and Services
Table 94. Fresenius Kabi AG Interchangeable Biosimilar Humira Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Fresenius Kabi AG Recent Developments/Updates
Table 96. Fresenius Kabi AG Competitive Strengths & Weaknesses
Table 97. Coherus BioSciences, Inc. Basic Information, Manufacturing Base and Competitors
Table 98. Coherus BioSciences, Inc. Major Business
Table 99. Coherus BioSciences, Inc. Interchangeable Biosimilar Humira Product and Services
Table 100. Coherus BioSciences, Inc. Interchangeable Biosimilar Humira Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Coherus BioSciences, Inc. Recent Developments/Updates
Table 102. Coherus BioSciences, Inc. Competitive Strengths & Weaknesses
Table 103. Biogen Inc. Basic Information, Manufacturing Base and Competitors
Table 104. Biogen Inc. Major Business
Table 105. Biogen Inc. Interchangeable Biosimilar Humira Product and Services
Table 106. Biogen Inc. Interchangeable Biosimilar Humira Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Biogen Inc. Recent Developments/Updates
Table 108. Biogen Inc. Competitive Strengths & Weaknesses
Table 109. AbbVie Inc. Basic Information, Manufacturing Base and Competitors
Table 110. AbbVie Inc. Major Business
Table 111. AbbVie Inc. Interchangeable Biosimilar Humira Product and Services
Table 112. AbbVie Inc. Interchangeable Biosimilar Humira Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. AbbVie Inc. Recent Developments/Updates
Table 114. AbbVie Inc. Competitive Strengths & Weaknesses
Table 115. Celltrion Inc. Basic Information, Manufacturing Base and Competitors
Table 116. Celltrion Inc. Major Business
Table 117. Celltrion Inc. Interchangeable Biosimilar Humira Product and Services
Table 118. Celltrion Inc. Interchangeable Biosimilar Humira Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Celltrion Inc. Recent Developments/Updates
Table 120. Celltrion Inc. Competitive Strengths & Weaknesses
Table 121. Amneal Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 122. Amneal Pharmaceuticals, Inc. Major Business
Table 123. Amneal Pharmaceuticals, Inc. Interchangeable Biosimilar Humira Product and Services
Table 124. Amneal Pharmaceuticals, Inc. Interchangeable Biosimilar Humira Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Amneal Pharmaceuticals, Inc. Recent Developments/Updates
Table 126. Amneal Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
Table 127. Lupin Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 128. Lupin Pharmaceuticals, Inc. Major Business
Table 129. Lupin Pharmaceuticals, Inc. Interchangeable Biosimilar Humira Product and Services
Table 130. Lupin Pharmaceuticals, Inc. Interchangeable Biosimilar Humira Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Lupin Pharmaceuticals, Inc. Recent Developments/Updates
Table 132. Lupin Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
Table 133. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 134. Merck & Co., Inc. Major Business
Table 135. Merck & Co., Inc. Interchangeable Biosimilar Humira Product and Services
Table 136. Merck & Co., Inc. Interchangeable Biosimilar Humira Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Merck & Co., Inc. Recent Developments/Updates
Table 138. Merck & Co., Inc. Competitive Strengths & Weaknesses
Table 139. Viatris Inc.imilar Basic Information, Manufacturing Base and Competitors
Table 140. Viatris Inc.imilar Major Business
Table 141. Viatris Inc.imilar Interchangeable Biosimilar Humira Product and Services
Table 142. Viatris Inc.imilar Interchangeable Biosimilar Humira Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Viatris Inc.imilar Recent Developments/Updates
Table 144. Amgen Inc. Basic Information, Manufacturing Base and Competitors
Table 145. Amgen Inc. Major Business
Table 146. Amgen Inc. Interchangeable Biosimilar Humira Product and Services
Table 147. Amgen Inc. Interchangeable Biosimilar Humira Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 148. Global Key Players of Interchangeable Biosimilar Humira Upstream (Raw Materials)
Table 149. Interchangeable Biosimilar Humira Typical Customers
Table 150. Interchangeable Biosimilar Humira Typical Distributors
LIST OF FIGURES
Figure 1. Interchangeable Biosimilar Humira Picture
Figure 2. World Interchangeable Biosimilar Humira Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Interchangeable Biosimilar Humira Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Interchangeable Biosimilar Humira Production (2018-2029) & (K Units)
Figure 5. World Interchangeable Biosimilar Humira Average Price (2018-2029) & (US$/Unit)
Figure 6. World Interchangeable Biosimilar Humira Production Value Market Share by Region (2018-2029)
Figure 7. World Interchangeable Biosimilar Humira Production Market Share by Region (2018-2029)
Figure 8. North America Interchangeable Biosimilar Humira Production (2018-2029) & (K Units)
Figure 9. Europe Interchangeable Biosimilar Humira Production (2018-2029) & (K Units)
Figure 10. China Interchangeable Biosimilar Humira Production (2018-2029) & (K Units)
Figure 11. Japan Interchangeable Biosimilar Humira Production (2018-2029) & (K Units)
Figure 12. Interchangeable Biosimilar Humira Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Interchangeable Biosimilar Humira Consumption (2018-2029) & (K Units)
Figure 15. World Interchangeable Biosimilar Humira Consumption Market Share by Region (2018-2029)
Figure 16. United States Interchangeable Biosimilar Humira Consumption (2018-2029) & (K Units)
Figure 17. China Interchangeable Biosimilar Humira Consumption (2018-2029) & (K Units)
Figure 18. Europe Interchangeable Biosimilar Humira Consumption (2018-2029) & (K Units)
Figure 19. Japan Interchangeable Biosimilar Humira Consumption (2018-2029) & (K Units)
Figure 20. South Korea Interchangeable Biosimilar Humira Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Interchangeable Biosimilar Humira Consumption (2018-2029) & (K Units)
Figure 22. India Interchangeable Biosimilar Humira Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Interchangeable Biosimilar Humira by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Interchangeable Biosimilar Humira Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Interchangeable Biosimilar Humira Markets in 2022
Figure 26. United States VS China: Interchangeable Biosimilar Humira Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Interchangeable Biosimilar Humira Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Interchangeable Biosimilar Humira Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Interchangeable Biosimilar Humira Production Market Share 2022
Figure 30. China Based Manufacturers Interchangeable Biosimilar Humira Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Interchangeable Biosimilar Humira Production Market Share 2022
Figure 32. World Interchangeable Biosimilar Humira Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Interchangeable Biosimilar Humira Production Value Market Share by Type in 2022
Figure 34. Subcutaneous (SC) Injection
Figure 35. Intravenous (IV) Infusion
Figure 36. World Interchangeable Biosimilar Humira Production Market Share by Type (2018-2029)
Figure 37. World Interchangeable Biosimilar Humira Production Value Market Share by Type (2018-2029)
Figure 38. World Interchangeable Biosimilar Humira Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Interchangeable Biosimilar Humira Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Interchangeable Biosimilar Humira Production Value Market Share by Application in 2022
Figure 41. Hospital Pharmacies
Figure 42. Retail Pharmacies
Figure 43. Online Pharmacies
Figure 44. World Interchangeable Biosimilar Humira Production Market Share by Application (2018-2029)
Figure 45. World Interchangeable Biosimilar Humira Production Value Market Share by Application (2018-2029)
Figure 46. World Interchangeable Biosimilar Humira Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Interchangeable Biosimilar Humira Industry Chain
Figure 48. Interchangeable Biosimilar Humira Procurement Model
Figure 49. Interchangeable Biosimilar Humira Sales Model
Figure 50. Interchangeable Biosimilar Humira Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
Figure 1. Interchangeable Biosimilar Humira Picture
Figure 2. World Interchangeable Biosimilar Humira Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Interchangeable Biosimilar Humira Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Interchangeable Biosimilar Humira Production (2018-2029) & (K Units)
Figure 5. World Interchangeable Biosimilar Humira Average Price (2018-2029) & (US$/Unit)
Figure 6. World Interchangeable Biosimilar Humira Production Value Market Share by Region (2018-2029)
Figure 7. World Interchangeable Biosimilar Humira Production Market Share by Region (2018-2029)
Figure 8. North America Interchangeable Biosimilar Humira Production (2018-2029) & (K Units)
Figure 9. Europe Interchangeable Biosimilar Humira Production (2018-2029) & (K Units)
Figure 10. China Interchangeable Biosimilar Humira Production (2018-2029) & (K Units)
Figure 11. Japan Interchangeable Biosimilar Humira Production (2018-2029) & (K Units)
Figure 12. Interchangeable Biosimilar Humira Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Interchangeable Biosimilar Humira Consumption (2018-2029) & (K Units)
Figure 15. World Interchangeable Biosimilar Humira Consumption Market Share by Region (2018-2029)
Figure 16. United States Interchangeable Biosimilar Humira Consumption (2018-2029) & (K Units)
Figure 17. China Interchangeable Biosimilar Humira Consumption (2018-2029) & (K Units)
Figure 18. Europe Interchangeable Biosimilar Humira Consumption (2018-2029) & (K Units)
Figure 19. Japan Interchangeable Biosimilar Humira Consumption (2018-2029) & (K Units)
Figure 20. South Korea Interchangeable Biosimilar Humira Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Interchangeable Biosimilar Humira Consumption (2018-2029) & (K Units)
Figure 22. India Interchangeable Biosimilar Humira Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Interchangeable Biosimilar Humira by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Interchangeable Biosimilar Humira Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Interchangeable Biosimilar Humira Markets in 2022
Figure 26. United States VS China: Interchangeable Biosimilar Humira Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Interchangeable Biosimilar Humira Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Interchangeable Biosimilar Humira Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Interchangeable Biosimilar Humira Production Market Share 2022
Figure 30. China Based Manufacturers Interchangeable Biosimilar Humira Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Interchangeable Biosimilar Humira Production Market Share 2022
Figure 32. World Interchangeable Biosimilar Humira Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Interchangeable Biosimilar Humira Production Value Market Share by Type in 2022
Figure 34. Subcutaneous (SC) Injection
Figure 35. Intravenous (IV) Infusion
Figure 36. World Interchangeable Biosimilar Humira Production Market Share by Type (2018-2029)
Figure 37. World Interchangeable Biosimilar Humira Production Value Market Share by Type (2018-2029)
Figure 38. World Interchangeable Biosimilar Humira Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Interchangeable Biosimilar Humira Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Interchangeable Biosimilar Humira Production Value Market Share by Application in 2022
Figure 41. Hospital Pharmacies
Figure 42. Retail Pharmacies
Figure 43. Online Pharmacies
Figure 44. World Interchangeable Biosimilar Humira Production Market Share by Application (2018-2029)
Figure 45. World Interchangeable Biosimilar Humira Production Value Market Share by Application (2018-2029)
Figure 46. World Interchangeable Biosimilar Humira Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. Interchangeable Biosimilar Humira Industry Chain
Figure 48. Interchangeable Biosimilar Humira Procurement Model
Figure 49. Interchangeable Biosimilar Humira Sales Model
Figure 50. Interchangeable Biosimilar Humira Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
